Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 04 Aug 2026 for Eledon Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleSteven Perrin
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -53.0%Entry US$2.51 · Close at T+365 US$1.18
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steven Perrin: trading record in brief
Steven Perrin discloses dealings in Eledon Pharmaceuticals, Inc. to SEC (Form 4). Between 23 November 2022 and 31 July 2026, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €2,519). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants.
The newest entry dates from 4 August 2026: a share grant, in Eledon Pharmaceuticals, Inc. The most recent open-market purchase was published on 23 November 2022, 1,425 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Steven Perrin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
152,353 shares0Common StockSEC:0001193125-26-333133:0
72,138 shares@ US$3.380.11% mcap98.8% of flowCommon StockSEC:0001193125-26-333133:1
1,000 shares@ US$2.59691.2% of flowCommon StockSEC:0001209191-22-058608:0
Canonical exit: 21 Feb 2023 (T+90)
3 of 3 declarations
